Save the date! 1st annual Bioelectronics and Nanomedicine Research Center Symposium is scheduled for September 26th. Featuring keynote speakers from California Institute of Technology and The State University of New York at Buffalo, and an internal speaker from the University of Kentucky. Other activities will include a poster session and a short “Meet the industry” session. Full agenda is below:
Registration for the symposium is not required but highly encouraged. Please, fill out the form to register.
Poster session guidelines:
The poster session will take place as part of the Bioelectronics and Nanomedicine Research Center Symposium on September 26th, 2024. The winners of the poster session will receive award prizes.
Space will be limited to the first 20 requests. Registration for the poster session is required. To register, please fill out the form. The posters submission deadline is September 19th (Thursday), 5 pm.
Poster dimensions should be 3’ x 4’.
About the speakers:
-
Wei Gao is a Professor of Medical Engineering, Ronald and JoAnne Willens Scholar, and Heritage Medical Research Institute Investigator in Division of Engineering and Applied Science at the California Institute of Technology. He received his Ph.D. in Chemical Engineering at the University of California, San Diego in 2014 as a Jacobs Fellow and an HHMI International Student Research Fellow. In 2014-2017, he was a postdoctoral fellow in the Department of Electrical Engineering and Computer Sciences at the University of California, Berkeley.
He is an Associate Editor of Science Advances (AAAS), npj Flexible Electronics (Nature Portfolio), Biosensors and Bioelectronics (Elsevier), and Sensors & Diagnosis (RSC). He is a recipient of NSF Career Award, ONR Young Investigator Award, IAMBE Early Career Award, Sloan Research Fellowship, 3M Non Tenured Faculty Award, Pittcon Achievement Award, IEEE EMBS Early Career Achievement Award, IEEE Sensor Council Technical Achievement Award, MIT Technology Review 35 Innovators Under 35, Falling Walls Breakthrough of the Year 2023 in Engineering and Technology, ACS DIC Young Investigator Award, and Materials Today Rising Star Award. He is a World Economic Forum Young Scientist, an American Cancer Society Research Scholar, a Highly Cited Researcher (Web of Science), a member of Global Young Academy, and a National Academy of Engineering’s USFOE alumnus. His research interests include wearable biosensors, digital medicine, bioelectronics, flexible electronics, and micro/nanorobotics. (Wei Gao - Division of Engineering and Applied Science (caltech.edu))
-
Jonathan F Lovell is Empire Innovation Professor of biomedical engineering at the State University of New York (SUNY) at Buffalo. He obtained a M.S. degree in Biochemistry at McMaster University working in the group of Dr. David Andrews where he studied the structure of Bcl-2 family proteins during membrane translocation. He pursued doctoral studies in biomedical engineering at the Institute of Biomaterials and Biomedical Engineering at University of Toronto under Dr. Gang Zheng. Since joining University at Buffalo, Dr. Lovell has been awarded an NIH Early Independence Award, the Rita Schaeffer Young Investigator Award and an NSF CAREER award. To date, he has co-authored over 50 peer-reviewed journal publications and numerous patents.
His current research interests include examining the dynamic structure of porphyrin-based nanovesicles loaded with crystalline drugs. Professor Lovell’s main focus is on developing novel nanomedicine approaches to meet unmet needs in treating, diagnosing or preventing disease. His group strive to use good engineering principles to iteratively design, synthesize, characterize, test and validate next generation nanoparticles and biosensors with the ultimate goal of making a translational impact on improving human health. Developing safer, organic nanoparticles that will allow superior treatment options for cancer therapy is a major research thrust. (Faculty Profile - Jacobs School of Medicine and Biomedical Sciences - University at Buffalo)
-
Dr. Gerhardt is Professor (with tenure) of Neuroscience, Neurosurgery, Neurology, Psychiatry, Electrical Engineering and Pharmaceutical Sciences at the University of Kentucky Health Sciences Center in Lexington, KY (USA). He currently holds the Charles D. Lucas, Jr. Endowed Professorship for Parkinson’s Disease Research. He has focused extensively on “bench-to-bedside” development of novel therapeutics, devices and therapies for Parkinson’s disease (PD) and PD research. He is also clinically certified in microelectrode recording (MER, 2012) for DBS surgery. He has published over 360 peer-reviewed papers and >80 book chapters.
Dr. Gerhardt directed the Phase I clinical trial on glial cell-line derived neurotrophic factor (GDNF) for Parkinson’s disease, which was a joint effort with Amgen. He has also been involved with the preclinical and clinical development of numerous drugs and devices with major biotechnology and pharmaceutical companies. In addition, he is known for his development and use of in-vivo biosensors with the formation of the Center for Microelectrode Technology in 1996. He is currently the Co-Director of the Neurorestoration Center, which was formed after his leadership of an NINDS Morris K. Udall Parkinson’s disease Research Center of excellence from 1999-2012. In his spare-time he enjoys scuba diving, down-hill skiing, flying in vintage airplanes and rebuilding “muscle” cars. (Greg Gerhardt, PhD | University of Kentucky College of Medicine (uky.edu))